Armata Pharmaceuticals, Inc. (ARMP) Financials

ARMP Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 90.0 million 321.1 million
March 31, 2026 69.8 million 381.4 million
Dec. 31, 2025 76.9 million 295.5 million
Sept. 30, 2025 89.5 million 185.1 million

ARMP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -8.7 million 3.4 million
March 31, 2026 -5.8 million 1.1 million
Dec. 31, 2025 -6.7 million 632000
Sept. 30, 2025 -4.5 million 622000

ARMP Net Income

No data available :(

ARMP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 24.0 million 42.0 million 25.8 million
March 31, 2026 4.8 million 342.9 million 30.8 million
Dec. 31, 2025 8.7 million 256.9 million 31.1 million
Sept. 30, 2025 14.8 million 15.2 million 31.4 million

ARMP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 62.0 million
March 31, 2026 36.5 million
Dec. 31, 2025 36.3 million
Sept. 30, 2025 36.2 million

ARMP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 17000 7.6 million 5.2 million -
March 31, 2026 63000 6.1 million 3.5 million -
Dec. 31, 2025 52000 6.1 million 3.4 million -
Sept. 30, 2025 242000 5.8 million 3.1 million -

ARMP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 2.5 million 591000
March 31, 2026 789000 457000
Dec. 31, 2025 1.1 million 418000
Sept. 30, 2025 1.2 million 370000

ARMP

Price: $5.38

52 week price:
2.76
16.34

Payout Ratio Range:
-11.71%
-0.66%

Earnings Per Share: -5.36 USD

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 6136

Market Capitalization: 214.4 million

Links: